Checkpoint Inhibitors Plus Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors

Дата публикации: 01-09-2023 00:00:00

This randomized clinical trial assesses the addition of radiotherapy to immune checkpoint inhibitors compared with immune checkpoint inhibitor monotherapy in patients with advanced solid tumors.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Neoadjuvant Immune Checkpoint Inhibitors in Early Breast Cancer	0	7.64	01-10-2024
2	Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy	0	11.16	01-06-2024
3	Bispecific Antibody Ivonescimab Added to Chemotherapy in EGFR -Variant Non–Small Cell Lung Cancer	0	10	28-07-2026
4	Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer	0	14.28	01-01-2025
5	Addition of High-Dose Vitamin D 3 to Standard Treatment for Metastatic Colorectal Cancer	0	13.41	03-08-2026
6	Cemiplimab and Fianlimab With Neoadjuvant Chemotherapy in Early-Stage High-Risk Breast Cancer	0	18.85	30-07-2026
7	Immune Checkpoint Inhibitors for Child-Pugh B Hepatocellular Carcinoma	0	11.22	01-10-2023
8	Cardiotoxicity of Immune Checkpoint Inhibitors	0	8	01-10-2024
9	Intraperitoneal and Intravenous Paclitaxel Plus S-1 for Gastric Cancer With Peritoneal Metastasis	0	4.7	01-07-2026
10	Troponin Screening and Major Cardiovascular Adverse Events During ICI Therapy	0	7.02	21-07-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 4.57. Источник: archderm.jamanetwork.com.